Insider Transactions in Q3 2021 at Boston Scientific Corp (BSX)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
3,321
-1.98%
|
$146,124
$44.88 P/Share
|
|
Sep 07
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
201,041
-8.81%
|
$8,845,804
$44.57 P/Share
|
|
Sep 07
2021
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
201,041
+4.28%
|
$1,206,246
$6.84 P/Share
|
|
Sep 01
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Open market or private sale
|
Direct |
728
-3.44%
|
$32,760
$45.33 P/Share
|
|
Aug 31
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Bona fide gift
|
Direct |
135
-0.1%
|
-
|
|
Aug 30
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Bona fide gift
|
Direct |
183
-0.14%
|
-
|
|
Aug 16
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
3,322
-1.94%
|
$146,168
$44.3 P/Share
|
|
Aug 10
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+18.85%
|
$260,000
$13.08 P/Share
|
|
Aug 05
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Open market or private sale
|
Direct |
41,741
-38.7%
|
$1,836,604
$44.14 P/Share
|
|
Aug 03
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
876
-3.98%
|
$39,420
$45.54 P/Share
|
|
Aug 03
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,973
+8.22%
|
-
|
|
Aug 02
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Open market or private sale
|
Direct |
727
-3.5%
|
$32,715
$45.77 P/Share
|
|
Aug 02
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
201,043
-8.81%
|
$9,046,935
$45.74 P/Share
|
|
Aug 02
2021
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
201,043
+4.28%
|
$1,206,258
$6.84 P/Share
|
|
Jul 27
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
9,673
-27.31%
|
$43,528,500
$4500.0 P/Share
|
|
Jul 27
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
4,250
+10.71%
|
$55,250
$13.08 P/Share
|
|
Jul 27
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
6,748
-4.82%
|
$303,660
$45.22 P/Share
|
|
Jul 27
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Open market or private sale
|
Direct |
105,490
-34.13%
|
$4,747,050
$45.0 P/Share
|
|
Jul 27
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
70,306
+18.53%
|
$421,836
$6.28 P/Share
|
|
Jul 27
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
SELL
Open market or private sale
|
Direct |
13,850
-41.98%
|
$623,250
$45.01 P/Share
|
|
Jul 27
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
BUY
Exercise of conversion of derivative security
|
Direct |
13,850
+29.57%
|
$318,550
$23.41 P/Share
|
|
Jul 27
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Open market or private sale
|
Direct |
728
-3.39%
|
$32,760
$45.0 P/Share
|
|
Jul 23
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Open market or private sale
|
Direct |
11,348
-34.54%
|
$499,312
$44.0 P/Share
|
|
Jul 23
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
11,348
+15.11%
|
$158,872
$14.7 P/Share
|
|
Jul 15
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
3,321
-1.9%
|
$139,482
$42.42 P/Share
|
|
Jul 06
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
201,041
-8.81%
|
$8,644,763
$43.41 P/Share
|
|
Jul 06
2021
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
201,041
+4.28%
|
$1,206,246
$6.84 P/Share
|
|
Jul 01
2021
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
214
-0.74%
|
$9,202
$43.36 P/Share
|
|
Jul 01
2021
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
728
+2.45%
|
-
|
|
Jul 01
2021
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
874
-6.28%
|
$37,582
$43.36 P/Share
|
|
Jul 01
2021
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Open market or private sale
|
Direct |
700
-4.79%
|
$29,400
$42.78 P/Share
|
|
Jul 01
2021
|
Scott Olson SVP & Pres, CRM, Diagnostics |
BUY
Exercise of conversion of derivative security
|
Direct |
1,771
+10.81%
|
-
|
|
Jul 01
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
SELL
Payment of exercise price or tax liability
|
Direct |
251
-1.34%
|
$10,793
$43.36 P/Share
|
|
Jul 01
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
BUY
Exercise of conversion of derivative security
|
Direct |
855
+4.38%
|
-
|